Cambridge Investment Research Advisors’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.3M | Sell |
3,267
-100
| -3% | -$28.5K | ﹤0.01% | 1909 |
|
|
2026
Q1 | $584K | Sell |
3,367
-754
| -18% | -$155K | ﹤0.01% | 2657 |
|
|
2025
Q4 | $1.05M | Sell |
4,121
-904
| -18% | -$237K | ﹤0.01% | 2051 |
|
|
2025
Q3 | $1.31M | Buy |
5,025
+440
| +10% | +$116K | ﹤0.01% | 1845 |
|
|
2025
Q2 | $1.12M | Sell |
4,585
-23
| -0.5% | -$5.73K | ﹤0.01% | 1858 |
|
|
2025
Q1 | $1.22M | Buy |
4,608
+145
| +3% | +$39.2K | ﹤0.01% | 1701 |
|
|
2024
Q4 | $1.13M | Sell |
4,463
-602
| -12% | -$161K | ﹤0.01% | 1766 |
|
|
2024
Q3 | $1.6M | Sell |
5,065
-796
| -14% | -$283K | 0.01% | 1522 |
|
|
2024
Q2 | $2.19M | Buy |
5,861
+1,017
| +21% | +$343K | 0.01% | 1224 |
|
|
2024
Q1 | $1.68M | Sell |
4,844
-5,479
| -53% | -$2.08M | 0.01% | 1382 |
|
|
2023
Q4 | $4.73M | Buy |
10,323
+1,127
| +12% | +$555K | 0.02% | 732 |
|
|
2023
Q3 | $4.47M | Buy |
9,196
+2,124
| +30% | +$998K | 0.02% | 711 |
|
|
2023
Q2 | $3.16M | Buy |
7,072
+1,577
| +29% | +$794K | 0.01% | 888 |
|
|
2023
Q1 | $2.67M | Sell |
5,495
-1,172
| -18% | -$579K | 0.01% | 975 |
|
|
2022
Q4 | $3.42M | Buy |
6,667
+1,575
| +31% | +$828K | 0.02% | 791 |
|
|
2022
Q3 | $2.47M | Buy |
5,092
+1,005
| +25% | +$489K | 0.01% | 920 |
|
|
2022
Q2 | $1.91M | Sell |
4,087
-157
| -4% | -$69.9K | 0.01% | 1070 |
|
|
2022
Q1 | $1.85M | Sell |
4,244
-1,408
| -25% | -$589K | 0.01% | 1183 |
|
|
2021
Q4 | $2.62M | Sell |
5,652
-1,727
| -23% | -$764K | 0.01% | 993 |
|
|
2021
Q3 | $2.87M | Sell |
7,379
-296
| -4% | -$126K | 0.01% | 891 |
|
|
2021
Q2 | $3.4M | Buy |
7,675
+4,032
| +111% | +$1.76M | 0.02% | 823 |
|
|
2021
Q1 | $1.53M | Buy |
3,643
+251
| +7% | +$100K | 0.01% | 1164 |
|
|
2020
Q4 | $1.39M | Sell |
3,392
-306
| -8% | -$127K | 0.01% | 1120 |
|
|
2020
Q3 | $1.53M | Sell |
3,698
-535
| -13% | -$215K | 0.01% | 945 |
|
|
2020
Q2 | $1.64M | Buy |
4,233
+614
| +17% | +$230K | 0.01% | 859 |
|
|
2020
Q1 | $1.14M | Sell |
3,619
-548
| -13% | -$185K | 0.01% | 910 |
|
|
2019
Q4 | $1.53M | Buy |
4,167
+104
| +3% | +$33K | 0.01% | 928 |
|
|
2019
Q3 | $1.04M | Sell |
4,063
-206
| -5% | -$57.8K | 0.01% | 1047 |
|
|
2019
Q2 | $1.13M | Sell |
4,269
-11,108
| -72% | -$2.82M | 0.01% | 965 |
|
|
2019
Q1 | $4.09M | Sell |
15,377
-559
| -4% | -$161K | 0.04% | 437 |
|
|
2018
Q4 | $4.57M | Buy |
15,936
+570
| +4% | +$181K | 0.05% | 355 |
|
|
2018
Q3 | $5.2M | Sell |
15,366
-63
| -0.4% | -$20.5K | 0.05% | 356 |
|
|
2018
Q2 | $4.59M | Buy |
15,429
+18
| +0.1% | +$5.27K | 0.05% | 364 |
|
|
2018
Q1 | $4.14M | Buy |
15,411
+12,039
| +357% | +$3.26M | 0.05% | 370 |
|
|
2017
Q4 | $836K | Buy |
3,372
+534
| +19% | +$132K | 0.01% | 994 |
|
|
2017
Q3 | $691K | Buy |
2,838
+743
| +35% | +$182K | 0.01% | 1033 |
|
|
2017
Q2 | $504K | Buy |
2,095
+92
| +5% | +$20.8K | 0.01% | 1196 |
|
|
2017
Q1 | $413K | Sell |
2,003
-2,473
| -55% | -$511K | 0.01% | 1171 |
|
|
2016
Q4 | $913K | Sell |
4,476
-132
| -3% | -$25.2K | 0.02% | 726 |
|
|
2016
Q3 | $815K | Sell |
4,608
-910
| -16% | -$158K | 0.02% | 779 |
|
|
2016
Q2 | $993K | Buy |
5,518
+143
| +3% | +$25.4K | 0.02% | 599 |
|
|
2016
Q1 | $983K | Buy |
5,375
+1,447
| +37% | +$251K | 0.02% | 582 |
|
|
2015
Q4 | $701K | Buy |
3,928
+1,000
| +34% | +$175K | 0.02% | 696 |
|
|
2015
Q3 | $524K | Sell |
2,928
-135
| -4% | -$25K | 0.02% | 738 |
|
|
2015
Q2 | $586K | Buy |
3,063
+2
| +0.1% | +$371 | 0.02% | 733 |
|
|
2015
Q1 | $545K | Buy |
3,061
+51
| +2% | +$8.07K | 0.02% | 752 |
|
|
2014
Q4 | $432K | Sell |
3,010
-1,164
| -28% | -$159K | 0.01% | 849 |
|
|
2014
Q3 | $544K | Buy |
4,174
+239
| +6% | +$30.4K | 0.02% | 790 |
|
|
2014
Q2 | $503K | Sell |
3,935
-230
| -6% | -$27.2K | 0.02% | 754 |
|
|
2014
Q1 | $470K | Buy |
4,165
+781
| +23% | +$81.4K | 0.02% | 740 |
|
|
2013
Q4 | $349K | Buy |
+3,384
| New | +$332K | 0.01% | 810 |
|
Other funds holding HUM
HGIM
PL
FFM
BPC
CNB
WC
Cambridge Investment Research Advisors's HUM Position: Q2 2026 in Review
Cambridge Investment Research Advisors reduced its Humana (HUM) stake by 3% in Q2 2026, selling an estimated $28.5K and leaving 3,267 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1909.
Cambridge Investment Research Advisors first reported a position in HUM in Q4 2013 and has held it in 51 quarters since. The position peaked at $5.2M in Q3 2018. 247 funds tracked by Wall St. Rank hold HUM as of Q2 2026.
- Cambridge Investment Research Advisors held 3,267 shares of Humana worth $1.3M as of Q2 2026.
- Cambridge Investment Research Advisors sold 100 Humana shares in Q2 2026, an estimated $28.5K.
- Humana made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1909 holding.
- Cambridge Investment Research Advisors first reported a position in Humana in Q4 2013 and has held it in 51 quarters since.
- Cambridge Investment Research Advisors's Humana position peaked at $5.2M in Q3 2018.
- 247 funds tracked by Wall St. Rank held Humana as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.